Lyden, P., Broderick, J., Grotta, J., Kwiatkowski, T., Levine, S., Frankel, M., . . . Tilley, B. (2023). The difference between concealment and blinding in clinical trials and why both are important. A reply to Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22: 17. BMC Medical Research Methodology, 23(1), 1. https://doi.org/10.1186/s12874-023-02074-5
Chicago Style (17th ed.) CitationLyden, Patrick, Joseph Broderick, James Grotta, Thomas Kwiatkowski, Steven Levine, Michael Frankel, E. Clarke Haley, and Barbara Tilley. "The Difference Between Concealment and Blinding in Clinical Trials and Why Both Are Important. A Reply To Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22: 17." BMC Medical Research Methodology 23, no. 1 (2023): 1. https://doi.org/10.1186/s12874-023-02074-5.
MLA (9th ed.) CitationLyden, Patrick, et al. "The Difference Between Concealment and Blinding in Clinical Trials and Why Both Are Important. A Reply To Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22: 17." BMC Medical Research Methodology, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12874-023-02074-5.